EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Rheumatoid arthritis is independently associated with metabolic Dysfunction-Associated steatotic liver disease: evidence from the paracelsus 10,000 Population-Based cohort study

Mathias Ausserwinkler iD, Axel J Hueber iD, Sophie Gensluckner iD, Bernhard Paulweber iD, Eugen Trinka iD, Patrick Langthaler iD, Christian Datz iD, Andreas Voelkerer iD, Franz Singhartinger iD, Bernhard Iglseder iD, Maria Flamm iD, Elmar Aigner iD und 1 weitere

Rheumatology International · 2025

DOI: 10.1007/s00296-025-06002-2 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Rheumatology International, 2025. Verfasst von Mathias Ausserwinkler und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Elisabethinen Hospital Klagenfurt, Klagenfurt, Austria. mathias.ausserwinkler@gmx.at. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Fatty Liver, Metabolic Syndrome. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Paracelsus Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Rheumatoid arthritis (RA) is associated with systemic inflammation and increased risk of cardiovascular and metabolic comorbidities. The relationship between RA and metabolic dysfunction-associated steatotic liver disease (MASLD) has not been established in population-based studies.

Methods

We conducted a cross-sectional analysis of 6638 participants from the population-based Paracelsus 10,000 cohort in Austria, including 187 individuals with physician-diagnosed RA meeting ACR/EULAR classification criteria. MASLD was defined using the Fatty Liver Index (≥ 60) combined with cardiometabolic risk factors according to 2024 EASL guidelines. We used Poisson regression models with sequential adjustment for demographic factors, metabolic syndrome, lifestyle factors, NSAID use, and cardiovascular risk (SCORE2). Liver fibrosis risk was assessed using the Fibrosis-4 Index (FIB-4).

Results

MASLD prevalence was higher in RA patients than controls (41.2% vs. 28.5%, P < 0.001). In sequential regression models, the association between RA and MASLD persisted after adjustment for demographics (IRR, 1.55; 95% CI 1.33–1.82), metabolic and lifestyle factors (IRR, 1.20; 95% CI 1.03–1.40), and cardiovascular risk factors (IRR, 1.35; 95% CI 1.14–1.60; P < 0.001). In addition, RA patients showed elevated liver fibrosis markers (median FIB-4: 1.21 vs. 1.08; P < 0.001).

Conclusions

In this population-based cohort, RA was independently associated with a 35% increased risk of MASLD and elevated liver fibrosis markers. These findings suggest that systematic liver assessment should be considered in the routine care of RA patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidFatty LiverMetabolic SyndromeHumansMaleFemaleMiddle AgedCross-Sectional StudiesAgedAustriaAdultPrevalenceCohort StudiesRisk FactorsLiver Cirrhosis

Stichwörter der Autor:innen

Cohort studiesFatty liverFibrosisMetabolic dysfunction-associated steatotic liver diseaseRheumatoid arthritisRisk factors

Autor:innen und Institutionen

  • Department of Internal Medicine, Elisabethinen Hospital Klagenfurt, Klagenfurt, Austria. mathias.ausserwinkler@gmx.at.
  • First Department of Medicine, Landeskrankenhaus-Uniklinikum Paracelsus Medical University Salzburg, Salzburg, Austria. mathias.ausserwinkler@gmx.at.
  • Division of Rheumatology, Klinikum Nuernberg, Paracelsus Medical University, Nürnberg, Germany.
  • First Department of Medicine, Landeskrankenhaus-Uniklinikum Paracelsus Medical University Salzburg, Salzburg, Austria.
  • Department of Neurology, Neurointensive Care and Neurorehabilitation, Member of the European Reference Network EpiCARE, Christian Doppler University Hospital, Centre for Cognitive Neuroscience, Paracelsus Medical Univer…
  • Neuroscience Institute, Christian Doppler University Hospital, Centre for Cognitive Neuroscience, Paracelsus Medical University Salzburg, Nürnberg, Austria.

ORCID-Profile: Mathias Ausserwinkler, Axel J Hueber, Sophie Gensluckner, Bernhard Paulweber, Eugen Trinka, Patrick Langthaler, Christian Datz, Andreas Voelkerer, Franz Singhartinger, Bernhard Iglseder, Maria Flamm, Elmar Aigner, Bernhard Wernly

Förderung

  • Paracelsus Medical University

Zitieren

APA

Ausserwinkler, M., Hueber, A. J., Gensluckner, S., Paulweber, B., Trinka, E., Langthaler, P., Datz, C., Voelkerer, A., Singhartinger, F., Iglseder, B., Flamm, M., Aigner, E., & Wernly, B. (2025). Rheumatoid arthritis is independently associated with metabolic Dysfunction-Associated steatotic liver disease: evidence from the paracelsus 10,000 Population-Based cohort study. Rheumatology International. https://doi.org/10.1007/s00296-025-06002-2

Vancouver

Ausserwinkler M, Hueber AJ, Gensluckner S, Paulweber B, Trinka E, Langthaler P, et al. Rheumatoid arthritis is independently associated with metabolic Dysfunction-Associated steatotic liver disease: evidence from the paracelsus 10,000 Population-Based cohort study. Rheumatology International. 2025. doi:10.1007/s00296-025-06002-2

BibTeX
@article{Ausserwinkler2025,
  author = {Ausserwinkler, Mathias and Hueber, Axel J and Gensluckner, Sophie and Paulweber, Bernhard and Trinka, Eugen and Langthaler, Patrick and Datz, Christian and Voelkerer, Andreas and Singhartinger, Franz and Iglseder, Bernhard and Flamm, Maria and Aigner, Elmar and Wernly, Bernhard},
  title = {Rheumatoid arthritis is independently associated with metabolic Dysfunction-Associated steatotic liver disease: evidence from the paracelsus 10,000 Population-Based cohort study},
  journal = {Rheumatology International},
  year = {2025},
  doi = {10.1007/s00296-025-06002-2}
}
Kostenlos starten →